Lionco Pharmaceutical GroupLtd Balance Sheet Health
Financial Health criteria checks 3/6
Lionco Pharmaceutical GroupLtd has a total shareholder equity of CN¥913.3M and total debt of CN¥465.2M, which brings its debt-to-equity ratio to 50.9%. Its total assets and total liabilities are CN¥1.5B and CN¥569.8M respectively.
Key information
50.9%
Debt to equity ratio
CN¥465.18m
Debt
Interest coverage ratio | n/a |
Cash | CN¥600.73m |
Equity | CN¥913.35m |
Total liabilities | CN¥569.82m |
Total assets | CN¥1.48b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 603669's short term assets (CN¥746.7M) exceed its short term liabilities (CN¥111.2M).
Long Term Liabilities: 603669's short term assets (CN¥746.7M) exceed its long term liabilities (CN¥458.6M).
Debt to Equity History and Analysis
Debt Level: 603669 has more cash than its total debt.
Reducing Debt: 603669's debt to equity ratio has increased from 27.6% to 50.9% over the past 5 years.
Debt Coverage: 603669's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 603669's interest payments on its debt are well covered by EBIT.